• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Perioperative atrial fibrillation and the long-term risk of ischemic stroke

, 26 August 2020/in E-News /by 3wmedia

What is the association between perioperative atrial fibrillation and the long-term risk of stroke?
This was a retrospective cohort study using administrative claims data on patients hospitalized for surgery (as defined by surgical diagnosis-related group codes), and discharged alive and free of documented cerebrovascular disease or pre-existing atrial fibrillation from non-federal California acute care hospitals between 2007 and 2011. Patients undergoing cardiac versus other types of surgery were analysed separately. Previously validated diagnosis codes were used to identify ischemic strokes after discharge from the index hospitalization for surgery. The primary predictor variable was atrial fibrillation newly diagnosed during the index hospitalization, as defined by previously validated present-on-admission codes. Patients were censored at post-discharge emergency department encounters or hospitalizations with a recorded diagnosis of atrial fibrillation.
Of 1,729,360 eligible patients, 24,711 (1.43%; 95% confidence interval [CI], 1.41%-1.45%) had new-onset perioperative atrial fibrillation during the index hospitalization and 13,952 (0.81%; 95% CI, 0.79%-0.82%) experienced a stroke after discharge. In a Cox proportional hazards analysis accounting for potential confounders, perioperative atrial fibrillation was associated with subsequent stroke both after non-cardiac and cardiac surgery. The association with stroke was significantly stronger for perioperative atrial fibrillation after non-cardiac versus cardiac surgery (p < 0.001 for interaction). For non-cardiac surgery, the cumulative rate of stroke 1 year after hospitalization was 1.47% in patients with perioperative atrial fibrillation and 0.36% when no perioperative atrial fibrillation was present (hazard ratio, 2.0; 95% CI, 1.7-2.3). For patients undergoing cardiac surgery, the cumulative risk of stroke 1 year after hospitalization was 0.99% with perioperative atrial fibrillation present, and 0.83% when no perioperative atrial fibrillation was present (hazard ratio, 1.3; 95% CI, 1.1-1.6).
Among patients hospitalized for surgery, perioperative atrial fibrillation was associated with an increased long-term risk of ischemic stroke, especially following non-cardiac surgery.
Atrial fibrillation, when first diagnosed in the perioperative period, especially after non-cardiac surgery, suggests patients

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:58Perioperative atrial fibrillation and the long-term risk of ischemic stroke

White Papers on quality control in POCT

, 26 August 2020/in E-News /by 3wmedia

Patient testing at the point-of-care has increased dramatically in recent years, as technology makes it more convenient to test patient samples at the bedside, which produces rapid results and allows immediate action. However, the benefits of this are only true if the results are both accurate and reliable, making quality control vitally important in the POC setting, just as it is in the laboratory. A recent survey in Ontario (Canada) identified that POCT is the largest source of error when compared to other sources of laboratory testing errors. Furthermore, the most common phase for errors in POCT is in the analytical stage, whereas in laboratory-based testing this is the least common source of errors. This highlights how vital it is to have a robust QC procedure in place for POCT as the potential risk of harm to a patient appears to be far greater for POC tests compared to those performed in a laboratory. Randox is launching a series of White Papers focusing on the importance of quality control in point-of-care testing (POCT). The White Papers are free to download and will help laboratories define an appropriate QC procedure for all POCT devices. The first White Paper covers the fundamentals of developing a POCT QC strategy in line with ISO15189 requirements, looking at who is responsible for QC, what QC is appropriate for different types of POC devices and tips for choosing IQC material and an EQA scheme. The second White Paper, scheduled for December, studies the importance of using 100% human serum controls to avoid lot-to-lot variations in immunoassay testing. The papers can be downloaded from the Randox website using the url below.

http://tinyurl.com/lcj2ry8
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:06White Papers on quality control in POCT

Detecting cancer earlier is goal of new medical imaging technology

, 26 August 2020/in E-News /by 3wmedia

A new medical imaging method being developed at Rutgers University could help physicians detect cancer and other diseases earlier than before, speeding treatment and reducing the need for invasive, time-consuming biopsies.
The potentially lifesaving technique uses nanotechnology to reveal small cancerous tumours and cardiovascular lesions deep inside the body. It is showing promise in early tests by Rutgers researchers in the schools of engineering and pharmacy.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:53Detecting cancer earlier is goal of new medical imaging technology

New measuring system to objectively ascertain the level of fatigue in physicians through eye movement

, 26 August 2020/in E-News /by 3wmedia

An international team of scientists including researchers from the U. of Granada find that the speed of saccadic movements (rapid eye movements) is an excellent way to objectively measure the level of fatigue in a physician.

Results prove that after a 24-hour medical shift, the speed of saccadic movements diminishes and the subjective perception of fatigue augments. However, the execution of simulated laparoscopic tests is not affected by this type of fatigue.

An international team of scientists which includes researchers from the U. of Granada has demonstrated for the first time that it is possible to establish in an objective way the level of fatigue in physicians after long shifts through their eye movement.

This research reveals that the speed of saccadic movement (mostly voluntary rapid eye movements which we use to focus our gaze upon an object that attracts our attention) is an excellent index to measure objectively the level of fatigue in the medical profession.

Results proved that after long hours, the speed of saccadic movements effectively diminished, while their subjective perception of fatigue increased. However, in the simulated laparoscopic tests after the shift, the execution was not affected in any significant way by their fatigue.

This means that

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:01New measuring system to objectively ascertain the level of fatigue in physicians through eye movement

New technology shows promise for delivery of therapeutics to the brain

, 26 August 2020/in E-News /by 3wmedia

A new technology that may assist in the treatment of brain cancer and other neurological diseases has recently been described

According to the authors, the current medical use of chemotherapy to treat brain cancer can be inefficient because of the blood-brain-barrier that impedes the delivery of drugs out of blood vessels and into the tumour.

The researchers from the Virginia Tech

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:08New technology shows promise for delivery of therapeutics to the brain

Personalized melanoma vaccines marshal powerful immune response

, 26 August 2020/in E-News /by 3wmedia

In a new approach, the cancer vaccines were developed by first sequencing the genomes of patients

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:48Personalized melanoma vaccines marshal powerful immune response

Cancer biopsies do not promote cancer spread

, 26 August 2020/in E-News /by 3wmedia

A study of more than 2,000 patients by researchers at Mayo Clinic

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:56Cancer biopsies do not promote cancer spread

Scientists find way to reduce ovarian cancer tumours, chemo doses

, 26 August 2020/in E-News /by 3wmedia

In a potential breakthrough against ovarian cancer, University of Guelph researchers have discovered how to both shrink tumours and improve drug delivery, allowing for lower doses of chemotherapy and reducing side effects.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:03Scientists find way to reduce ovarian cancer tumours, chemo doses

Anderson Algorithm increases surgical success with advanced ovarian cancer

, 26 August 2020/in E-News /by 3wmedia

A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumour

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:51Anderson Algorithm increases surgical success with advanced ovarian cancer

Involuntary eye movement a fool-proof indication for ADHD diagnosis

, 26 August 2020/in E-News /by 3wmedia

Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:58Involuntary eye movement a fool-proof indication for ADHD diagnosis
Page 132 of 234«‹130131132133134›»

Latest issue of International Hospital

April 2024

21 August 2025

Paper mills: Researchers uncover scientific fraud networks that threaten research integrity at industrial scale

21 August 2025

OmicsTweezer breakthrough: Advanced AI tool transforms cancer tissue analysis

20 August 2025

New CRISPR editing technique removes methylation marks to reactivate silenced genes

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription